India Generic Injectables Market Overview 2021: Size, Share, Growth and Forecast 2026
According to the latest report by IMARC Group, titled “India Generic Injectables Market Size: Industry Trends, Share, Growth, Opportunity and Forecast 2021-2026,” the india generic injectables market is expected to continue its robust growth in the forecast period (2021-2026).
Generic injectables are pharmaceutical drugs with the similar
active ingredients, strength, dosage, and administration route as that of their
branded injectables. Some of common product variants, include Prevnar 13,
Eliquis, Ibrance, Lyrica, Xeljanz, etc. Generic injectables facilitate the
quick onset of action, precise and adjustable dosing, and predictable
bioavailability. Moreover, these injectables cost lesser than their branded
counterparts, which helps in managing overhead costs related to pharma
products.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
India Generic Injectables Market Trends:
The growing prevalence of
chronic diseases in India, due to unhealthy dietary habits and sedentary
lifestyles of the consumers, is primarily catalyzing the market for generic
injectables market. Furthermore, the increasing investments by the Indian
government to introduce innovative generic injectables for providing effective
drug administration and enabling faster recovery of patients are also providing
a thrust to the market. Additionally, several technological advancements in the
drug delivery systems, such as the introduction of self-injection devices, are
propelling the market growth. Various other factors, including increasing
penetration of health insurance companies and the upcoming patent expiry of
several blockbuster medicines, are expected to further drive the market growth
over the forecasted period.
Request Free Sample Report: https://www.imarcgroup.com/india-generic-injectables-market/requestsample
India Generic Injectables Market 2021-2026 Analysis and Segmentation:
Breakup by Therapeutic Area:
- Oncology
- Anaesthesia
- Anti-infectives
- Parenteral
Nutrition
- Cardiovascular
Breakup by Container:
- Vials
- Ampoules
- Premix
- Prefilled
Syringes
Breakup by Distribution Channel:
- Hospitals
- Retail
Pharmacy
Breakup by Region:
- North
India
- West
and Central India
- South
India
- East
India
Ask Analyst for Customization and Explore Full Report with TOC &
List of Figure: https://www.imarcgroup.com/india-generic-injectables-market
Key highlights of the report:
- Market
Performance (2015-2020)
- Market
Outlook (2021- 2026)
- Porter’s
Five Forces Analysis
- Market
Drivers and Success Factors
- SWOT
Analysis
- Value
Chain
- Comprehensive
Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope
of the report, we can provide it to you as a part of the customization.
If you want latest primary and secondary data (2021-2026) with Cost
Module, Business Strategy, Distribution Channel, etc. Click request free sample
report, published report will be delivered to you in PDF format via email
within 24 to 48 hours of receiving full payment.
About Us
IMARC Group is a leading market research company that offers management
strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most
critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic
and technological developments for business leaders in pharmaceutical,
industrial, and high technology organizations. Market forecasts and industry
analysis for biotechnology, advanced materials, pharmaceuticals, food and
beverage, travel and tourism, nanotechnology and novel processing methods are
at the top of the company’s expertise.
Contact Us:
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Comments
Post a Comment